The Cancer Prevention and Control Program (CPC) represents a realignment of the former two population sciences programs (Cancer Control and Carcinogenesis, Biomarkers and Epidemiology). As the nexus for population science-focused research at Lombardi, the mission of CPC is to conduct population sciences research across the translational spectrum from discovery to interventions to policy. To accomplish this mission, we conduct research around four distinct themes and one cross-cutting theme. Theme 1 - Liver and Bladder Cancer focuses on investigation of environmental, genetic, and behavioral risks and biomarkers associated with liver and bladder cancer occurrence and early detection. Theme 2 - Translational Genomics focuses on investigations of cancer genetic/genomic risk testing to inform prevention, improve patient outcomes, and develop interventions to enhance clinical and policy translation. Theme 3 - Treatment and Survivorship focuses on cancer treatment and survivorship outcomes and the development of interventions to improve these outcomes. Theme 4 - Modeling focuses on population risk prediction and the impact of cancer control interventions to inform clinical practice and policy debates about the most effective and cost-effective care. In addition to these distinct themes. Cancer Disparities is a cross-cutting theme that is integrated within each ofthe four distinct programmatic foci. The program has 24 members, led by Marc Schwartz, PhD, and Christopher Loffredo, PhD, and includes faculty from 7 Departments and 2 institutions. Total direct funding is $11M in the last budget year, of which $6.7M is from the NCI (direct costs). Program members published 357 peer-reviewed publications during the current funding period of which 34% were intraprogrammatic, 22% were interprogrammatic and 63% involved external collaborators. Program members used all but one of the Shared Resources. The CPC addresses the cancer control needs of our catchment area through a strong research program focused on lifestyle, cancer-related behaviors, and health system factors. Research in the catchment area is facilitated through two community-based research sites: the Capital Breast Care Center and a new community-based center for disparities research and outreach located in Southeast DC. In addition to support of these community-based sites, Lombardi has added value to CPC through the recruitment and support of 12 new faculty members, investment in infrastructure, including laboratories, and support for biostatistics and bioinformatics.

Public Health Relevance

The goal of CPC is to translate population science 'discoveries' into developing and testing interventions, applying effective interventions to the clinic and populations, and assessing policy and practice implications. To accomplish this goal, the program conducts research around four distinct thematic areas (Liver and Bladder Cancer Research, Translational Genomics Research, Treatment and Survivorship Research, and Modeling Research), with cancer disparities as an integrated cross-cutting theme.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA051008-25
Application #
9483616
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2018-05-01
Budget End
2019-04-30
Support Year
25
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Georgetown University
Department
Type
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Lee, Yichien; Rodriguez, Olga C; Albanese, Chris et al. (2018) Divergent brain changes in two audiogenic rat strains: A voxel-based morphometry and diffusion tensor imaging comparison of the genetically epilepsy prone rat (GEPR-3) and the Wistar Audiogenic Rat (WAR). Neurobiol Dis 111:80-90
Coia, Heidi; Ma, Ning; Hou, Yanqi et al. (2018) Prevention of Lipid Peroxidation-derived Cyclic DNA Adduct and Mutation in High-Fat Diet-induced Hepatocarcinogenesis by Theaphenon E. Cancer Prev Res (Phila) 11:665-676
Ory, Virginie; Kietzman, William B; Boeckelman, Jacob et al. (2018) The PPAR? agonist efatutazone delays invasive progression and induces differentiation of ductal carcinoma in situ. Breast Cancer Res Treat 169:47-57
Ozawa, Patricia Midori Murobushi; Alkhilaiwi, Faris; Cavalli, Iglenir João et al. (2018) Extracellular vesicles from triple-negative breast cancer cells promote proliferation and drug resistance in non-tumorigenic breast cells. Breast Cancer Res Treat 172:713-723
Smith, Jill P; Wang, Shangzi; Nadella, Sandeep et al. (2018) Cholecystokinin receptor antagonist alters pancreatic cancer microenvironment and increases efficacy of immune checkpoint antibody therapy in mice. Cancer Immunol Immunother 67:195-207
Edwardson, Matthew A; Zhong, Xiaogang; Fiandaca, Massimo S et al. (2018) Plasma microRNA markers of upper limb recovery following human stroke. Sci Rep 8:12558
Kaat, Aaron J; Schalet, Benjamin D; Rutsohn, Joshua et al. (2018) Physical function metric over measure: An illustration with the Patient-Reported Outcomes Measurement Information System (PROMIS) and the Functional Assessment of Cancer Therapy (FACT). Cancer 124:153-160
Maximov, Philipp Y; Abderrahman, Balkees; Fanning, Sean W et al. (2018) Endoxifen, 4-Hydroxytamoxifen and an Estrogenic Derivative Modulate Estrogen Receptor Complex Mediated Apoptosis in Breast Cancer. Mol Pharmacol 94:812-822
Czarnecka, Magdalena; Lu, Congyi; Pons, Jennifer et al. (2018) Neuropeptide Y receptor interactions regulate its mitogenic activity. Neuropeptides :
Gonzalez, Thomas L; Moos, Rebecca K; Gersch, Christina L et al. (2018) Metabolites of n-Butylparaben and iso-Butylparaben Exhibit Estrogenic Properties in MCF-7 and T47D Human Breast Cancer Cell Lines. Toxicol Sci 164:50-59

Showing the most recent 10 out of 1120 publications